Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006441
Status:
COMPLETED
Last Update Posted:
2015-03-09
First Post:
2000-11-03
Brief Title:
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| Acute Infection | View |
| Virus Replication | View |
| HIV-1 | View |
| Interleukin-2 | View |
| Drug Therapy Combination | View |
| Zidovudine | View |
| HIV Protease Inhibitors | View |
| CD4-Positive T-Lymphocytes | View |
| CD8-Positive T-Lymphocytes | View |
| Biological Markers | View |
| Lamivudine | View |
| Reverse Transcriptase Inhibitors | View |
| Anti-HIV Agents | View |
| Nelfinavir | View |
| Cytotoxicity Immunologic | View |